Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Enrofloxacin via Dermal, Inhaled, and Oral Dosing
NCT03575312Phase 1Completed
- Sponsor
- Fraunhofer ITEM
- Start
- Apr 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of enrofloxacin, sponsored by Fraunhofer ITEM. Primary endpoints: Maximum concentration of enrofloxacin in plasma at 24 hours and Pharmacokinetic assessment of enrofloxacin in urine. Started Apr 2018; status: completed.
02
Drugs
enrofloxacin
Beyond the preview
Go deeper on NCT03575312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03575312.